CONSOLIDATED STATEMENTS OF CONVERTIBLE COMMON SHARES AND SHAREHOLDERS' EQUITY - USD ($) $ in Thousands	Total	Common Stock	Common Stock Convertible Common Shares	Additional Paid-in Capital	Accumulated Other Comprehensive Income (loss)	Retained Earnings
Balance at Dec. 31, 2021	$ 2,562,444	$ 20,281		$ 1,811,545	$ (5,948)	$ 736,566
Balance, Shares at Dec. 31, 2021		162,251,000	1,512,000
Net issuance of common stock under stock-based plans	(4,375)	$ 96		(4,471)
Net issuance of common stock under stock-based plans (in shares)		761,000
Stock-based compensation expense	48,466			48,466
Repurchase of common stock	(752,082)	$ (907)				(751,175)
Repurchase of common stock (in shares)		(7,253,000)
Cash dividends	(69,763)					(69,763)
Settlements of convertible notes	(255)	$ 187		(442)
Settlement of convertible notes (in shares)		1,495,000
Exercise of convertible notes hedge call options	0	$ (187)		187
Exercise of convertible notes hedge call options (in shares)		(1,495,000)
Convertible common shares	1,512			1,512
Convertible common shares (in shares)			(1,512,000)
Cumulative-effect of change in accounting principle related to convertible debt	(6,234)			(100,834)		94,600
Net income	715,501					715,501
Other comprehensive income (loss)	(43,920)				(43,920)
Balance at Dec. 31, 2022	2,451,294	$ 19,470		1,755,963	(49,868)	725,729
Balance, Shares at Dec. 31, 2022		155,759,000	0
Net issuance of common stock under stock-based plans	13,477	$ 106		13,371
Net issuance of common stock under stock-based plans (in shares)		848,000
Stock-based compensation expense	57,940			57,940
Repurchase of common stock	(400,529)	$ (489)				(400,040)
Repurchase of common stock (in shares)		(3,909,000)
Cash dividends	(67,927)					(67,927)
Settlements of convertible notes	0	$ 133		(133)
Settlement of convertible notes (in shares)		1,072,000
Exercise of convertible notes hedge call options	0	$ (133)		133
Exercise of convertible notes hedge call options (in shares)		(1,072,000)
Net income	448,752					448,752
Other comprehensive income (loss)	22,890				22,890
Balance at Dec. 31, 2023	2,525,897	$ 19,087		1,827,274	(26,978)	706,514
Balance, Shares at Dec. 31, 2023		152,698,000	0
Net issuance of common stock under stock-based plans	23,228	$ 91		23,137
Net issuance of common stock under stock-based plans (in shares)		728,000
Stock-based compensation expense	60,397			60,397
Warrant exercises	(16)	$ 1,254		(1,270)
Warrant exercises (in shares)		10,036,000
Repurchase of common stock	(201,883)	$ (217)				(201,666)
Repurchase of common stock (in shares)		(1,740,000)
Cash dividends	(76,459)					(76,459)
Net income	542,372					542,372
Other comprehensive income (loss)	(54,242)				(54,242)
Balance at Dec. 31, 2024	$ 2,819,294	$ 20,215		$ 1,909,538	$ (81,220)	$ 970,761
Balance, Shares at Dec. 31, 2024		161,722,000	0